41
Participants
Start Date
March 8, 2013
Primary Completion Date
October 15, 2021
Study Completion Date
March 21, 2024
Brentuximab Vedotin
Given IV
Dacarbazine
Given IV
Doxorubicin Hydrochloride
Given IV
Pharmacological Study
Correlative studies
Vinblastine
Given IV
Memorial Sloan Kettering Cancer Center, New York
Montefiore Medical Center-Einstein Campus, The Bronx
Pennsylvania Hospital, Philadelphia
Fox Chase Cancer Center, Philadelphia
Johns Hopkins University/Sidney Kimmel Cancer Center, Baltimore
Centre Hospitalier Universitaire (CHU) de Toulouse, Cedex
Chu Purpan, Toulouse
University of Miami Miller School of Medicine-Sylvester Cancer Center, Miami
John H Stroger Jr Hospital of Cook County, Chicago
Siteman Cancer Center at Washington University, St Louis
Washington University - Jewish, St Louis
Washington University School of Medicine, St Louis
Centre Hospitalier Lyon-Sud, Pierre-Bénite
Louisiana State University Health Science Center, New Orleans
Hopital Saint Louis, Paris
Hospital Saint-Antoine, Paris
UCLA Center for Clinical AIDS Research and Education, Los Angeles
UCLA / Jonsson Comprehensive Cancer Center, Los Angeles
UC San Diego Moores Cancer Center, La Jolla
Hopital Antoine Beclere, Clamart
Henri Mondor University-Hospital Center, Créteil
University of California Davis Comprehensive Cancer Center, Sacramento
Virginia Mason Medical Center, Seattle
Harborview Medical Center, Seattle
Fred Hutchinson Cancer Center, Seattle
Boston Medical Center, Boston
Beth Israel Deaconess Medical Center, Boston
Hopital l'Archet-CHU de Nice, Nice
The Lymphoma Academic Research Organisation
OTHER
National Cancer Institute (NCI)
NIH